Clinical Experience (Pre And Post Licensing) In Previously Ert-Naove Patients Receiving Velaglucerase Alfa For Type 1 Gaucher Disease

JOURNAL OF INHERITED METABOLIC DISEASE(2011)

Cited 0|Views12
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined